Journal article
Crystal structure of the PIM2 kinase in complex with an organoruthenium inhibitor.
- Abstract:
-
BACKGROUND: The serine/threonine kinase PIM2 is highly expressed in human leukemia and lymphomas and has been shown to positively regulate survival and proliferation of tumor cells. Its diverse ATP site makes PIM2 a promising target for the development of anticancer agents. To date our knowledge of catalytic domain structures of the PIM kinase family is limited to PIM1 which has been extensively studied and which shares about 50% sequence identity with PIM2. PRINCIPAL FINDINGS: Here we deter...
Expand abstract
- Publication status:
- Published
Actions
Authors
Funding
Canadian Institutes for Health Research
More from this funder
Canadian Foundation for Innovation
More from this funder
Ontario Genomics Institute
More from this funder
GlaxoSmithKline
More from this funder
Karolinska Institutet
More from this funder
Expand funders...
Bibliographic Details
- Publisher:
- Public Library of Science Publisher's website
- Journal:
- PloS one Journal website
- Volume:
- 4
- Issue:
- 10
- Article number:
- e7112
- Publication date:
- 2009-01-01
- DOI:
- EISSN:
-
1932-6203
- ISSN:
-
1932-6203
- Source identifiers:
-
34939
Item Description
- Language:
- English
- Keywords:
- UUID:
-
uuid:75641f80-06c0-4e70-925f-48b0614b6a27
- Local pid:
- pubs:34939
- Deposit date:
- 2012-12-19
Terms of use
- Copyright holder:
- Bullock et al
- Copyright date:
- 2009
- Notes:
- Copyright 2009 Bullock et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record